Survodutide 10 mg

Survodutide 10 mg by Stealth Labs

Survodutide is a dual GLP-1/glucagon receptor agonist that shows strong promise in weight reduction and liver fat reduction studies. This 10 mg peptide by Stealth Labs is formulated for advanced research into metabolic disorders and obesity management.

What is Survodutide?

Survodutide targets both GLP-1 and glucagon receptors to suppress appetite, enhance energy expenditure, and improve insulin sensitivity. According to clinical trials published in NEJM, it has produced significant reductions in body weight among patients with or without diabetes.

Benefits of Survodutide Research

• Appetite suppression through dual receptor activation
• Promotes fat oxidation and energy expenditure
• Reduces visceral fat and improves liver function
• Supports glycemic control and metabolic health

Dosage & Administration

Each vial contains 10 mg of Survodutide in a 2 mL solution. For research use, it is commonly administered subcutaneously once weekly. Dosage should begin low and gradually escalate under clinical protocols. This formulation is not for human use without proper authorization.

Related Research Compounds

To optimize metabolic pathways, researchers often stack Survodutide with:

• Stealth Labs Semaglutide 10 mg
• Stealth Labs Mazdutide 10 mg
• Dragon Pharma Tesamorelin 5 mg
• Stealth Labs Somatropin 100 IU

For regenerative goals, many add this enhanced GLP-1/glucagon peptide version to improve results.

Lab Test Report

Frequently Asked Questions